Recipient Outcomes after ABO-Incompatible Liver Transplantation: A Systematic Review and Meta-Analysis

被引:86
作者
Wu, Jian [1 ,2 ,3 ]
Ye, SunYi [1 ,2 ,3 ]
Xu, XiaoFeng [1 ,2 ,3 ]
Xie, Haiyang [1 ,2 ,3 ]
Zhou, Lin [1 ,2 ,3 ]
Zheng, ShuSen [1 ,2 ,3 ]
机构
[1] Zhejiang Univ, Key Lab Combined Multi Organ Transplantat, Minist Publ Hlth, Affiliated Hosp 1,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Key Lab Organ Transplantat, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Univ, Div Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Sch Med,Dept Surg, Hangzhou 310003, Zhejiang, Peoples R China
关键词
SINGLE-CENTER; COMPLICATIONS; AGE; IMMUNOSUPPRESSION; FIBROSIS; THERAPY; FAILURE; RISK;
D O I
10.1371/journal.pone.0016521
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: ABO-incompatible live transplantation (ILT) is not occasionally performed due to a relative high risk of graft failure. Knowledge of both graft and patient survival rate after ILT is essential for donor selection and therapeutic strategy. We systematically reviewed studies containing outcomes after ILT compared to that after ABO-compatible liver transplantation (CLT). Methodology/Principal Findings: We carried out a comprehensive search strategy on MEDLINE (1966-July 2010), EMBASE (1980-July 2010), Biosis Preview (1969-July 2010), Science Citation Index (1981-July 2010), Cochrane Database of Systematic Reviews (Cochrane Library, issue 7, 2010) and the National Institute of Health (July 2010). Two reviewers independently assessed the quality of each study and abstracted outcome data. Fourteen eligible studies were included which came from various medical centers all over the world. Meta-analysis results showed that no significantly statistical difference was found in pediatric graft survival rate, pediatric and adult patient survival rate between ILT and CLT group. In adult subgroup, the graft survival rate after ILT was significantly lower than that after CLT. The value of totally pooled OR was 0.64 (0.55, 0.74), 0.92 (0.62, 1.38) for graft survival rate and patient survival rate respectively. The whole complication incidence (including acute rejection and biliary complication) after ILT was higher than that after CLT, as the value of totally pooled OR was 3.02 (1.33, 6.85). Similarly, in acute rejection subgroup, the value of OR was 2.02 (1.01, 4.02). However, it was 4.08 (0.90, 18.51) in biliary complication subgroup. Conclusions/Significance: In our view, pediatric ILT has not been a contraindication anymore due to a similar graft and patient survival rate between ILT and CLT group. Though adult graft survival rate is not so satisfactory, ILT is undoubtedly life-saving under exigent condition. Most studies included in our analysis are observational researches. Larger scale of researches and Randomized-Control Studies are still needed.
引用
收藏
页数:10
相关论文
共 39 条
[1]
Highly urgent liver transplantation:: Possible impact of donor-recipient ABO matching on the outcome after transplantation [J].
Bjoro, K ;
Ericzon, BG ;
Kirkegaard, P ;
Höckerstedt, K ;
Söderdahl, G ;
Olausson, M ;
Foss, A ;
Schmidt, LE ;
Isoniemi, H ;
Brandsæter, B ;
Friman, S .
TRANSPLANTATION, 2003, 75 (03) :347-353
[2]
Liver transplantation across Rh blood group barriers increases the risk of biliary complications [J].
Busquets, Juli ;
Castellote, Jose ;
Torras, Jaume ;
Fabregat, Juan ;
Ramos, Emilio ;
Llado, Laura ;
Rafecas, Antonio ;
de la Banda, Esmeralda ;
Figueras, Juan .
JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (04) :458-463
[3]
A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION [J].
CACCIARELLI, TV ;
SO, SKS ;
LIM, J ;
CONCEPCION, W ;
COX, K ;
ESQUIVEL, CO .
TRANSPLANTATION, 1995, 60 (07) :757-760
[4]
ABO blood group incompatibility in liver transplantation: A single-centre experience [J].
Chui, AKK ;
Ling, J ;
McCaughan, GW ;
Painter, D ;
Shun, A ;
Dorney, SFA ;
Mears, DC ;
Sheil, AGR .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1997, 67 (05) :275-278
[5]
DEMETRIS AJ, 1988, AM J PATHOL, V132, P489
[6]
Present status of ABO-incompatible living donor liver transplantation in japan [J].
Egawa, Hiroto ;
Teramukai, Satoshi ;
Haga, Hironori ;
Tanabe, Mnoru ;
Fukushima, Masanori ;
Shirnazu, Motohide .
HEPATOLOGY, 2008, 47 (01) :143-152
[7]
Liver transplantation across the ABO barrier: The role of plasmapheresis [J].
Eid, A ;
Zamir, G ;
Yaron, I ;
Galun, E ;
Safadi, R ;
Schaaps, T ;
Berlatzky, Y ;
Shouval, D ;
Jurim, O .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (03) :701-703
[8]
THE USE OF ABO-INCOMPATIBLE GRAFTS IN LIVER-TRANSPLANTATION - A LIFESAVING PROCEDURE IN HIGHLY SELECTED PATIENTS [J].
FARGES, O ;
KALIL, AN ;
SAMUEL, D ;
SALIBA, F ;
ARULNADEN, JL ;
DEBAT, P ;
BISMUTH, A ;
CASTAING, D ;
BISMUTH, H .
TRANSPLANTATION, 1995, 59 (08) :1124-1133
[9]
Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection [J].
Fehr, Thomas ;
Ruesi, Barbara ;
Fischer, Andreas ;
Hopfer, Helmut ;
Wuethrich, Rudolf P. ;
Gaspert, Ariana .
TRANSPLANTATION, 2009, 87 (12) :1837-1841
[10]
SERUM HEMOLYTIC CLASSICAL AND ALTERNATIVE PATHWAYS OF COMPLEMENT IN INFANCY - AGE-RELATED-CHANGES [J].
FERRIANI, VPL ;
BARBOSA, JE ;
DECARVALHO, IF .
ACTA PAEDIATRICA SCANDINAVICA, 1990, 79 (03) :322-327